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ABSTRACT:  Effect  of  Immue-21  (an  herbal  immunomodulator)  was  studied  on  different 
immunopharmacological  models.    Immue-21  significantly  enhanced  the  mobilization  and 
functional capacity of peritoneal macrophages of experimental animals.  An elevated blastofenic 
response  of  splenic  lymphocytes  was  observed  in  Immue-21  treated  mice.    The  potential  to 
modulate  the  immunity  in  general  by  Immue-21  assumes  considerable  therapeutic  and/or 
prophylactic significance. 
 
INTRODUCTION 
 
In  recent  years,  the  field  of 
immunomodulation  attracts  attention  of 
scientists, in view of the growing awareness 
regarding  the  need  to  modulate  the  host 
immune  system  to  achieve  the  desirable 
effects of preventing an infection rather than 
treating it at an advanced stage. 
 
Different  immunomodulators  of  chemical 
origin  are  currently  in  use  to  enhance  the 
non-specific  host  resistance  against 
infections.  However, the major drawbacks 
of these substances are their prohibitive cost 
and  development  of  local  reactions  with 
associated side effects.   The use of herbal 
products  to  restore  and  rejuvenate  positive 
health and to maintain organic balance, has 
been in vogue since ancient times
1. 
 
Immue-21, a herbal  formulation of  Indian 
Herbs,  Saharanpur,  containing 
immunoactive  plant  principles  of  Ocimum 
Sactum   and  Withania  somnifera  has  been 
reported  to  potentiate  non-specific  defence 
mechanism  of  the  host  and  thus  helps  to 
overcome infective processes
2. 
 
Immunomodulators  have  been  shown  to 
produce their effects through different ways.  
We  have  investigated  the  possible 
mechanism of action of Immue-21 through 
different experimental models in our present 
study. 
 
MATERIALS AND METHODS 
 
Immunomodulatory effect of Immue-21 was 
assessed  using  adult  male  albino  mice 
(Approx.30gm).    The  animals  were 
acclimatized  to  laboratory  conditions  for 
seven days prior to experimentation.  They 
were  grouped  in  polycarbonate  cages  in  a 
centrally air conditioned room at an ambient 
temperature of 22
0 ± 1
0 C with 12 hour light 
and  dark  cycle.    The  animals  were 
maintained  on  pellet  diet  (JDB  Agency, 
New Delhi) and water ad libitum. 
 
The experimental animals were divided into 
three  groups  of  six  animals  each.    The 
animals of Group-I served as vehicle treated 
control.    The  animals  of  Group-II  and  III 
were  treated  with  Immue-21  at  the  dose 
level  of  20  and  200  mg/kg  body  weight, 
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respectively,  for  15  days  (20  mg  is 
recommended dose and 200 mg is ten times 
higher  dose  to  observe  adverse  effects,  if 
any).  Test product was dissolved in distilled 
water (10 mg/ml) and given by intragastric 
route using tuberculin syringe equipped with 
blunted  21  gauge  needle  tipped  with 
polyethylene tubing daily at 10.00 AM. 
 
All the animals were challenged (I.P) with 
same  quantity  of  non-pathogenic 
Staphylococcus  sp.  On  13
th  day  of 
experiment  of  non-specific  antigen.  
Peritoneal  cells  from  each  animal  were 
collected  on  16
th  day.    Macrophages  were 
isolated by adhering on glass surfaces
3 and 
counted using haemocytometer. 
 
Phagocytic  activity  was  assessed  using 
reduction  of  nitroblue  tetrazolium  by 
macrophages in terms of formazan produced 
by 1 * 10
6 cells, expressed as optical density 
(OD) measured at   515 nm
4. 
 
Spleen  from  each  animal  was  collected 
aseptically.  Spleenocytes were prepared in 
cold  RPMI-1640  as  described  elsewhere
5.  
Cell  counts  were  made  using 
haemocytometer.    Percentile  blastogenic 
transformation of spleenic lymphocytes was 
assessed by morphological identification of 
blast.    Number  of  blasts  cells  were 
calculated  as  medium  and  large  size 
lymphocytes with dividing stage of nuclei
6. 
 
Statistical  analysis  of  the  data  generated 
during  the  course  of  study  was  done  by 
student’s-t test
7. 
 
RESULTS 
 
Effects  of  Immue-21  on  peritoneal 
macrophages  of  the  experimental  animals 
are  presented  in  Table-I.    Significant 
increases  in  the  number  and  phagocytic 
activity  of  peritoneal  macrophages  was 
observed in mice treated with Immue-21 at 
the  dose  of  20  mg/kg.    No  significant 
alteration regarding the number and activity 
of  macrophages  was  noticed  in  the  mice 
treated with Immue-21 at higher dose level. 
 
Immue-21  treatment  did  not  significantly 
alter  the  weight  of  spleen  of  the 
experimental  animals.    The  cell  counts  in 
spleen  showed  in  increase  in  lymphocyte 
number  in  the  animals  (Group-II)  as 
compared  to  control  (Table-II).    The 
viability of the cells were not altered when 
tested  by  trypan  blue  method.    Percentile 
count  showed  increased  number  of 
lymphoblasts in the spleen of product treated 
animals (Group-II). 
 
DISCUSSION 
 
Macrophages  are  the  major  constituent  of 
mononuclear  phagocyte  system  of  an 
individual.    They  play  a  central  role  in 
modulating cell mediated immunity
8.  In our 
present  study,  increase  in  the    number  of 
peritoneal  macrophages  in  product  treated 
animals  (20  mg/kg)  suggests  that  the 
component(s)  of  Immue-21  directly  or 
indirectly  stimulate  the  proliferation  of 
macrophages.  The results also indicate the 
Immue-21 stimulates the phagocytic activity 
of  macrophages  at  20  mg/kg  dose  level.  
Activated macrophages can release different 
cytokines  which  are  having 
immunomodulatory  actions  like  antigen 
presentation,  lymphocyte  activation  and 
tumoricidal activity
9,10.  Very high dose of 
Immue-21 (200 mg/kg) did not significantly 
influence  the  number  and  activity  of 
macrophages. 
 
Activation  of  macrophages  by  Immue-21 
may be due to the fact that glycosides from 
W. somnifera (one of the major constituents 
of  this  product)  produce  significant 
mobilization  and  activation  of  peritoneal 
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macrophages  with  increased  phagocytic 
activity and lysosomal enzyme secretion by 
activated  macrophages
11.    Increased 
phagocytic  activity  of  the  peritoneal 
macrophages  of  mice  treated  with  W. 
somnifera  over  the  control  animals  was 
previously reported.  It was suggested that 
W.  somnifera  primarily  activated 
macrophages which in turn secrete cytokines 
to  stimulate  other  immunocytes  like 
neutrophils
12,13.    In  an  earlier  experiment
2, 
identical modulatory effect of Immue-21 on 
microbicidal  activity  of  neutrophils  was 
noticed.    The  present  study  supports  the 
previous  one  by  showing  the  influence  of 
the  product  on  functional  properties  of 
macrophages  suggesting  a  possible  role  in 
immunomodulation. 
 
Lymphocytes  are  the  key  cells,  generally 
referred  to  as  immunocytes  and  once 
sensitized  with  antigen  become  committed 
for  the  production  of  antibodies.    In  our 
earlier study it was found that the number of 
lymphocytes  was  increased  in  product 
treated  animals
2.    The  lymphocytes  are 
primarily stored in the spleen, a secondary 
lymphoid  organ  that  controls  immue 
response of an individual. 
 
In he present study, increase in the number 
of spleenic lymphocytes and conversion of 
small  lymphocytes  to  blast  cells  of  the 
product  treated  mice  (20  mg/kg)  after 
antigenic  challenge  provided  the  basis  for 
immunopotentiation by  this  compound.   A 
high count of lymphoblasts indicates that the 
lymphocytes have undergone transformation 
and  confirm  their  sensitivity  to  antigen, 
suggesting that Immue-21 improves the T-
cell memory of the individuals. 
 
Based on the present study, it can safely be 
presumed  that  Immue-21  at  recommended 
dose  level  is  a  potent  immunostimulator 
with  considerable  therapeutic  significance.  
At  a  very  high  dose,  it  has  no  significant 
effect on host immue system.  It is hoped 
that  these  observations,  which  are  quite 
preliminary,  will  stimulate  further 
investigations of this product with a view to 
discover a non-toxic immunomodulator that 
may have unique potential to treat or prevent 
immue-based diseases. 
 
Table – I Effect of IMMUE-21 on Peritoneal Macrophages 
 
Treatment  Number of macrophages 
per ml. of peritoneal 
exudates (*10
6) 
Phagocytic activity of 
macrophages (1*10) (O.D. 
of formazan) 
I.   Vehicle  7.68 ± 0.38  0.472 ± 0.015 
II.  Immue-21 (20 mg/kg)  12.59 ± 0.27 *  0.601 ± 0.019 * 
III. Immue-21 (200 mg/kg)  7.19 ± 1.27  0.460 ± 0.009 
* Significant difference (P<0.01) compared to control animals. 
 
Table – I Effect of IMMUE-21 on Peritoneal Macrophages 
 
Group / Treatment  Number / gm of  Spleen  
(*10
6) 
Percent blast cells 
I.   Vehicle control  247.2 ± 3.57  18.29 ± 0.37 
II.  Immue-21 (20 mg/kg)  270.3 ± 7.32*  24.71 ± 0.52* 
III. Immue-21 (200 mg/kg)  248.0 ± 7.95  19.21 ± 0.48 
* Significant difference (P<0.01) compared to control animals. 
Pages 250 - 253  4 
 
REFERENCES 
 
1.  Sharma, D.N.K. and Khosa, R.L. Immunomodulators of plant origin –A review. (1994) Anc. 
Sci. Life. 13 : 326-331. 
 
2.  Chatterjee, S. Modulation of host immune function by Immue-21 (Research name) – An 
experimental study (1994) Ind. J. Med. 11. in press. 
 
3.  Hudson,  L.  and  Hay,  F.C.  In.  Practical  Immunology  (3
rd  Edn.)  Blackwell  Scientifica 
Publications.  Oxford, London (1980) pp. 27-28. 
 
4.  Saxena,  A.K.,  ;  Singh,  K.P.;  Srivastava,  S.N.;  Khanna,  S.;  Shukla,  L.J  and  Shankar,  R. 
Immunomodulating effects of caffeine ( 1,3,7 – trimethyl xanthine) in rodents (1984) Ind. J. 
Exp. Biol. 22 : 298 – 301. 
 
5.  Ford, W.L. The preparation and labeling of Lymphocytes.  In Handbook of Experimental 
Immunology  (Vol-2)  Cellular  Immunology  (D.M.  Wier  ed.)    Blackwell  Scientific 
Publications.  Oxford, London (1978) p.23. 
 
6.  Paul, B.N. and Chakraborty, A.K. Phytohaemagglutinin mediated activation of bat (Pteropus 
giganteus)  Lymphocytes (1987). Ind. J. Exp. Biol. 25 : 1-4. 
 
7.  Snedecor,  G.W  and  Cochran,  W.G.  In  Statistical  Methods  (6
th  edn.).    Oxford  and  IBH 
Publishing Co. Pvt. Ltd. New Delhi, Bombay, Calcutta (1967). 
 
8.  Hunt, J.S. Cytokine networks in the utero placental unit: macrophages as pivotal regulatory 
cells. (1989) J. Reprod. Immunol. 16 : 1-17. 
 
9.  Dinarello, C.A.; Clark, B.D.; Puren, A.J.; Savage, N and Rosoff, P.M.  The IL-1 receptors 
(1989) Immunol.  Today. 10  : 49-58. 
 
10. Fiers, W. Tumor necrosis factor : Characterization at the molecular, cellular and  in vitro 
level. (1991) FEBS Lett. 285: 199 – 212. 
 
11. Ghosal, S.; Lal,; Srinivastava, R; Bhattacharya, S.K. ; Upadhyay, S.N. ; Jaiswal, A.K. and 
Chattopadhyay, U. IX and X, two new glycol withanolides from Withania somnifera (1989).  
Phytother.  Res. 3 : 201 – 206. 
 
12. Thatte,  U.M.  and  Dahanukar,  S.A.  Immunotherapeutic  modification  of  experimental 
infections by Indian medicinal plants. (1989) Phytother. Res. 3 : 43 – 49. 
 
13. Praveen  Kumar,  V.;  Kuttan,  R.  and  Kuttan,  G.  Usefulness  of  rasayanas  as 
immunomodulators and chemoprotectors against cyclophosphamide induced toxicity (1994) 
Amala Res. Bull. 14 : 49-51.   
Pages 250 - 253